-+ 0.00%
-+ 0.00%
-+ 0.00%

MediciNova CEO Iwaki base salary rises to $690,246 under new employment agreement

PUBT·08/19/2026 11:31:31
Listen to the news
MediciNova CEO Iwaki base salary rises to $690,246 under new employment agreement
  • MediciNova signed new executive employment agreements on Aug. 17, 2026 for CEO Yuichi Iwaki, CMO Kazuko Matsuda.
  • Iwaki base salary set at USD 690,246; target annual bonus set at 55% of base salary.
  • Matsuda base salary set at USD 540,143; target annual bonus set at 40% of base salary.
  • Involuntary termination without a change in control triggers 12 months’ salary severance, up to 12 months of company-paid COBRA.
  • Change-in-control involuntary termination triggers 24 months’ pay for Iwaki, 18 months for Matsuda, both with target bonus and full equity vesting.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MediciNova Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-356146), on August 19, 2026, and is solely responsible for the information contained therein.